Researchers sought to determine whether chemotherapy consolidated by autoSCT would yield the same survival results as alloSCT in patients with PTCL.

The FDA has approved Ensacove (ensartinib) to treat patients with ALK+ advanced NSCLC who have not previously received an ALK inhibitor.

CAIRO, Dec 10 (Reuters) - A U.S.-based charity, the World Central Kitchen, fired dozens of Palestinians working for the charity in the Gaza Strip, at least three workers told Reuters, after Israel ...

Two of the most common B-cell lymphomas are diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma ... followed by autologous stem cell transplant, or ASCT. CNS prophylaxis, or administering ...

SHANGHAI, Dec 7 (Reuters) - China's central bank resumed buying gold for its reserves in November after a six-month pause, official data by the People's Bank of China (PBOC) showed on Saturday ...

The tumors accumulate 18 F-fluorodeoxyglucose during PET. Leptomeningeal lymphoma occurs rarely, and is seen as linear areas of enhancement within the subarachnoid spaces overlying the cortex ...

The rebels’ gains prompted Lebanon and Jordan to close border crossings and Iran to begin withdrawing personnel from Syria. By Raja Abdulrahim Farnaz Fassihi and Thomas Fuller The collection of ...

The heart has long been thought to be controlled solely by the autonomic nervous system, which transmits signals from the brain. The heart's neural network, which is embedded in the superficial ...